Reported resultsCompany-reported
What was reported
BOSTON – July 30, 2026 – Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, “Ginkgo”) today announced that it plans to host a presentation and Q&A session reviewing business performance for the second quarter ended June 30, 2026, on Wednesday, August 5, 2026, beginning at 4:30 p.m. ET.U.S. Securities and Exchange Commission (EDGAR) · Exhibit 99.1 to 8-K · Jul 30, 2026 · Open the source ↗
What the evidence supports
Ginkgo Bioworks published its results for the period in a press release furnished to the SEC (Form 8-K, Item 7.01).
What remains unknown
Audit status of the figures (results furnished on Form 8-K or 6-K are typically unaudited), and anything about future periods. Any outlook is the company's own projection. Figures and claims are the company's own description and have not been independently verified.
Source passages
Exact excerpts from the source, with links. Quotes are checked character for character against our stored copy.
Press release headlineGinkgo Bioworks Announces Date of Second Quarter 2026 Results PresentationU.S. Securities and Exchange Commission (EDGAR) · Exhibit 99.1 to 8-K · Jul 30, 2026 · Open the source ↗
Press release lead paragraphBOSTON – July 30, 2026 – Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, “Ginkgo”) today announced that it plans to host a presentation and Q&A session reviewing business performance for the second quarter ended June 30, 2026, on Wednesday, August 5, 2026, beginning at 4:30 p.m. ET.U.S. Securities and Exchange Commission (EDGAR) · Exhibit 99.1 to 8-K · Jul 30, 2026 · Open the source ↗
Revision history
- Revision 1 · Oct 28, 2026, 20:53 UTC
Ginkgo Bioworks Announces Date of Second Quarter 2026 Results Presentation
Spotted an error? Tell us. Corrections are published, never silent: see all corrections.